CARDIO METABOLIC RISK

Clinical trials for CARDIO METABOLIC RISK explained in plain language.

Never miss a new study

Get alerted when new CARDIO METABOLIC RISK trials appear

Sign up with your email to follow new studies for CARDIO METABOLIC RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Hormone pill may cut heart risk in perimenopause, small study suggests

Disease control Completed

This completed Phase 3 trial tested whether taking 50 mg of prasterone (DHEA) daily for 2 months could improve cardiometabolic indicators in perimenopausal women. The study enrolled 25 women and measured changes in insulin resistance and lipid levels. The goal is to find a way to…

Matched conditions: CARDIO METABOLIC RISK

Phase: PHASE3 • Sponsor: Universidad de Guanajuato • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

CARDIO METABOLIC RISK

Get alerted when new CARDIO METABOLIC RISK trials appear

Hormone pill may cut heart risk in perimenopause, small study suggests